HYPD Stock Summary and Trading Ideas (Hyperion Defi | NASDAQ:HYPD)

Eyenovia Inc is a clinical-stage ophthalmic company developing a pipeline of therapeutics based on its proprietary array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Optejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance, and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies that target new indications or New combinations.

What symbol and exchange does Hyperion Defi shares trade?

Hyperion Defi trades on the NASDAQ stock market under the symbol HYPD.

What is Hyperion Defi stock price doing today?

As of December 31, 2025, HYPD stock price climbed to $3.56 with 322,558 million shares trading.

What is Hyperion Defi's Beta?

HYPD has a beta of 5.41, meaning it tends to be more sensitive to market movements. HYPD has a correlation of 0.10 to the broad based SPY ETF.

How much is Hyperion Defi worth?

HYPD has a market cap of $29.09 million. This is considered a Sub-Micro Cap stock.

What are the top ETFs holding Hyperion Defi?

The top ETF exchange traded funds that HYPD belongs to (by Net Assets): VXF.

What are the support and resistance levels for Hyperion Defi (HYPD)?

HYPD support price is $3.10 and resistance is $3.64 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HYPD shares will trade within this expected range on the day.